
Carolyn L. Smith
Examiner (ID: 10258)
| Most Active Art Unit | 1631 |
| Art Unit(s) | 1631 |
| Total Applications | 423 |
| Issued Applications | 101 |
| Pending Applications | 54 |
| Abandoned Applications | 268 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 13222671
[patent_doc_number] => 10125100
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-11-13
[patent_title] => Kinase inhibitors
[patent_app_type] => utility
[patent_app_number] => 15/604258
[patent_app_country] => US
[patent_app_date] => 2017-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 80007
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 696
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15604258
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/604258 | Kinase inhibitors | May 23, 2017 | Issued |
Array
(
[id] => 13748691
[patent_doc_number] => 10167276
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-01-01
[patent_title] => Compounds and methods for inhibiting JAK
[patent_app_type] => utility
[patent_app_number] => 15/601324
[patent_app_country] => US
[patent_app_date] => 2017-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 36
[patent_no_of_words] => 36000
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15601324
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/601324 | Compounds and methods for inhibiting JAK | May 21, 2017 | Issued |
Array
(
[id] => 14684859
[patent_doc_number] => 20190241544
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-08
[patent_title] => TETRAHYDROPYRAN AND THIOPYRAN DERIVATIVES HAVING MULTIMODAL ACTIVITY AGAINST PAIN
[patent_app_type] => utility
[patent_app_number] => 16/301508
[patent_app_country] => US
[patent_app_date] => 2017-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38466
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16301508
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/301508 | Tetrahydropyran and thiopyran derivatives having multimodal activity against pain | May 18, 2017 | Issued |
Array
(
[id] => 13714221
[patent_doc_number] => 20170368065
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-28
[patent_title] => DEUTERATED COMPOUNDS FOR TREATING CANCER AND RELATED DISEASES AND CONDITIONS, AND COMPOSITIONS AND METHODS THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/599415
[patent_app_country] => US
[patent_app_date] => 2017-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9899
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15599415
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/599415 | Deuterated compounds for treating cancer and related diseases and conditions, and compositions and methods thereof | May 17, 2017 | Issued |
Array
(
[id] => 12054706
[patent_doc_number] => 20170331050
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-16
[patent_title] => 'COMPOUND AND ORGANIC PHOTOELECTRIC DEVICE, IMAGE SENSOR AND ELECTRONIC DEVICE INCLUDING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 15/591259
[patent_app_country] => US
[patent_app_date] => 2017-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 22623
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15591259
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/591259 | Compound and organic photoelectric device, image sensor and electronic device including the same | May 9, 2017 | Issued |
Array
(
[id] => 14309547
[patent_doc_number] => 20190144477
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-16
[patent_title] => FOSAPREPITANT PHOSPHATE INTERMEDIATE AND PREPARATION METHOD THEREFOR
[patent_app_type] => utility
[patent_app_number] => 16/099157
[patent_app_country] => US
[patent_app_date] => 2017-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3146
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16099157
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/099157 | Fosaprepitant phosphate intermediate and preparation method therefor | May 8, 2017 | Issued |
Array
(
[id] => 12051140
[patent_doc_number] => 20170327483
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-16
[patent_title] => 'Pyridinyl derivatives, pharmaceutical compositions and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 15/588739
[patent_app_country] => US
[patent_app_date] => 2017-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16794
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15588739
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/588739 | Pyridinyl derivatives, pharmaceutical compositions and uses thereof | May 7, 2017 | Issued |
Array
(
[id] => 13079291
[patent_doc_number] => 10059703
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-08-28
[patent_title] => 3-alkyl-5-fluoro-4-substituted-imino-3,4-dihydropyrimidin-2(1
[patent_app_type] => utility
[patent_app_number] => 15/589733
[patent_app_country] => US
[patent_app_date] => 2017-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12311
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 451
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15589733
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/589733 | 3-alkyl-5-fluoro-4-substituted-imino-3,4-dihydropyrimidin-2(1 | May 7, 2017 | Issued |
Array
(
[id] => 12526803
[patent_doc_number] => 10005777
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-06-26
[patent_title] => Protein kinase C inhibitors and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/588410
[patent_app_country] => US
[patent_app_date] => 2017-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 100675
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 173
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15588410
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/588410 | Protein kinase C inhibitors and uses thereof | May 4, 2017 | Issued |
Array
(
[id] => 15977889
[patent_doc_number] => 10669252
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-02
[patent_title] => Benzazepine derivative, preparation method, pharmaceutical composition and use thereof
[patent_app_type] => utility
[patent_app_number] => 16/098972
[patent_app_country] => US
[patent_app_date] => 2017-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29892
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 902
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16098972
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/098972 | Benzazepine derivative, preparation method, pharmaceutical composition and use thereof | May 3, 2017 | Issued |
Array
(
[id] => 14309425
[patent_doc_number] => 20190144416
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-16
[patent_title] => INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE
[patent_app_type] => utility
[patent_app_number] => 16/098239
[patent_app_country] => US
[patent_app_date] => 2017-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20031
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 150
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16098239
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/098239 | Inhibitors of indoleamine 2,3-dioxygenase and methods of their use | May 3, 2017 | Issued |
Array
(
[id] => 14438857
[patent_doc_number] => 20190177301
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-13
[patent_title] => SIGMA RECEPTOR BINDERS
[patent_app_type] => utility
[patent_app_number] => 16/097233
[patent_app_country] => US
[patent_app_date] => 2017-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29016
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16097233
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/097233 | Sigma receptor binders | Apr 28, 2017 | Issued |
Array
(
[id] => 15245181
[patent_doc_number] => 10508103
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-12-17
[patent_title] => Benzimidazole-linked indole compound acting as novel divalent IAP antagonist
[patent_app_type] => utility
[patent_app_number] => 16/096848
[patent_app_country] => US
[patent_app_date] => 2017-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25956
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16096848
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/096848 | Benzimidazole-linked indole compound acting as novel divalent IAP antagonist | Apr 26, 2017 | Issued |
Array
(
[id] => 11836230
[patent_doc_number] => 20170217950
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-03
[patent_title] => 'Bicyclo[3.2.1]Octyl Amide Derivatives and Uses of Same'
[patent_app_type] => utility
[patent_app_number] => 15/489971
[patent_app_country] => US
[patent_app_date] => 2017-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30595
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15489971
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/489971 | Bicyclo[3.2.1]Octyl Amide Derivatives and Uses of Same | Apr 17, 2017 | Abandoned |
Array
(
[id] => 14777843
[patent_doc_number] => 20190263819
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-29
[patent_title] => HETEROCYCLIC COMPOUNDS AS RET KINASE INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/093858
[patent_app_country] => US
[patent_app_date] => 2017-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30254
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16093858
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/093858 | Heterocyclic compounds as RET kinase inhibitors | Apr 17, 2017 | Issued |
Array
(
[id] => 13916505
[patent_doc_number] => 10202360
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-02-12
[patent_title] => Therapeutic compounds
[patent_app_type] => utility
[patent_app_number] => 15/488674
[patent_app_country] => US
[patent_app_date] => 2017-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 51468
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15488674
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/488674 | Therapeutic compounds | Apr 16, 2017 | Issued |
Array
(
[id] => 11993917
[patent_doc_number] => 20170298069
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-19
[patent_title] => 'INHIBITORS OF ACTIVIN RECEPTOR-LIKE KINASE'
[patent_app_type] => utility
[patent_app_number] => 15/488257
[patent_app_country] => US
[patent_app_date] => 2017-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 146200
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15488257
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/488257 | Inhibitors of activin receptor-like kinase | Apr 13, 2017 | Issued |
Array
(
[id] => 14611457
[patent_doc_number] => 10358414
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-07-23
[patent_title] => Substituted N-acetyl-L-cysteine derivatives and related compounds
[patent_app_type] => utility
[patent_app_number] => 15/481728
[patent_app_country] => US
[patent_app_date] => 2017-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 36
[patent_no_of_words] => 12216
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15481728
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/481728 | Substituted N-acetyl-L-cysteine derivatives and related compounds | Apr 6, 2017 | Issued |
Array
(
[id] => 13026309
[patent_doc_number] => 10035770
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-07-31
[patent_title] => Compounds, compositions and methods
[patent_app_type] => utility
[patent_app_number] => 15/480618
[patent_app_country] => US
[patent_app_date] => 2017-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25043
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15480618
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/480618 | Compounds, compositions and methods | Apr 5, 2017 | Issued |
Array
(
[id] => 11757201
[patent_doc_number] => 20170204069
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-20
[patent_title] => 'N-(SUBSTITUTED)-5-FLUORO-4-IMINO-3-METHYL-2-OXO-3,4-DIHYDROPYRIMIDINE-1(2H)-CARBOXYLATE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 15/480040
[patent_app_country] => US
[patent_app_date] => 2017-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7998
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15480040
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/480040 | N-(substituted)-5-fluoro-4-imino-3-methyl-2-oxo-3,4-dihydropyrimidine-1(2H)-carboxylate derivatives | Apr 4, 2017 | Issued |